Three excellent studies, three answers: How much protection do omicron vaccines provide?

vaccination illustration
Photo: EPA-EFE

Three studies published yesterday offered more evidence that covid-19 vaccines are effective in protecting against the omicron variant, at least in those who received the third dose of the vaccine.

These are the first major US studies dealing with the protection provided by omicron vaccines, health officials said.

Studies have shown the results of previous studies, including studies in Germany, South Africa and the United Kingdom, which show that available vaccines are less effective against the omicron variant than previous coronavirus variants, but that the third dose significantly intensifies protection.

Hospitalization

The first study looked at hospitalizations and ambulance visits in 10 US states from August to January.

The efficacy of the vaccine has been found to be best after three doses of Pfizer or Moderna vaccine in the prevention of covid-19 emergency care.

Protection fell from 94 percent during the delta wave to 82 percent during the omicron wave.

Protection against only two doses was less, especially if six months had elapsed since the second dose.

Mortality

Another study focused on covid-19 cases and mortality rates in 25 US states from early April to Christmas.

People who received the third dose of the vaccine were more protected from coronavirus infection, both at a time when delta was predominant and at a time when omicron was predominant.

Both articles were published online by the Centers for Disease Control and Prevention (CDC). The Journal of the American Medical Association published the third study, which was also conducted by CDC researchers.

Overflowing coyote

They tested people who tested positive for covid-19 from December 10 to January 1 at more than 4.600 test sites across the United States.

Three doses of Pfizer and Modern vaccines were about 67 percent effective against omicron-related symptomatic diseases compared to unvaccinated people.

However, both doses did not provide significant protection against the omicron strain, the researchers found.

 

 

Dear reader,

Our access to web content is free, because we believe in equality in information, regardless of whether someone can pay or not. Therefore, in order to continue our work, we ask for the support of our community of readers by financially supporting the Free Press. Become a member of Sloboden Pechat to help the facilities that will enable us to deliver long-term and quality information and TOGETHER let's ensure a free and independent voice that will ALWAYS BE ON THE PEOPLE'S SIDE.

SUPPORT A FREE PRESS.
WITH AN INITIAL AMOUNT OF 60 DENARS

Video of the day